Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Arrowhead Pharma (ARWR)

Arrowhead Pharma (ARWR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,399,845
  • Shares Outstanding, K 95,708
  • Annual Sales, $ 168,800 K
  • Annual Income, $ 67,970 K
  • 60-Month Beta 1.97
  • Price/Sales 32.38
  • Price/Cash Flow 73.69
  • Price/Book 22.19

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.04
  • Number of Estimates 4
  • High Estimate 0.12
  • Low Estimate -0.11
  • Prior Year 0.13
  • Growth Rate Est. (year over year) -130.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
54.19 +4.12%
on 01/13/20
68.35 -17.45%
on 12/19/19
-9.43 (-14.32%)
since 12/17/19
3-Month
35.03 +61.06%
on 10/21/19
73.72 -23.47%
on 11/29/19
+19.82 (+54.15%)
since 10/17/19
52-Week
12.51 +351.00%
on 01/23/19
73.72 -23.47%
on 11/29/19
+41.79 (+285.65%)
since 01/17/19

Most Recent Stories

More News
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Arrowhead Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of...

ARWR : 56.42 (-1.21%)
After Yesterday's Decline of 3.81%, Arrowhead Pharma Offers Investors Better Value

Arrowhead Pharma (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $54.19 to a high of $58.00. Yesterday, the shares fell 3.8%, which took the trading range below the 3-day low of...

ARWR : 56.42 (-1.21%)
Shares of ARWR Up 97.4% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Arrowhead Pharma (NASDAQ:ARWR) on October 4th, 2019 at $30.12. In approximately 3 months, Arrowhead Pharma has returned 97.38% as of today's recent price of $59.44....

ARWR : 56.42 (-1.21%)
Arrowhead Pharmaceuticals Appoints James Hassard as Chief Commercial Officer

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced the appointment of James Hassard to the newly-created position of chief commercial officer. Mr. Hassard will be responsible for driving commercial...

ARWR : 56.42 (-1.21%)
Relatively Good Performance Detected in Shares of Epizyme Inc in the Biotechnology Industry (EPZM , AIMT , AKBA , ARWR, ATRA )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

AIMT : 34.92 (-4.49%)
AKBA : 8.03 (+3.21%)
EPZM : 26.72 (+4.62%)
ARWR : 56.42 (-1.21%)
Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar?

Style Box ETF report for FNY

FNY : 49.47 (-0.18%)
IWP : 158.91 (+0.01%)
ARWR : 56.42 (-1.21%)
CVNA : 84.00 (-3.68%)
ROKU : 130.38 (-0.53%)
IJK : 243.26 (-0.16%)
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

PSCH : 136.52 (-0.39%)
XLV : 104.49 (unch)
VHT : 196.84 (-0.11%)
MDCO : 84.90 (-0.07%)
LHCG : 145.42 (+1.56%)
ARWR : 56.42 (-1.21%)
Arrowhead Pharmaceuticals Doses First Patient in AROAAT2002 Open Label Phase 2 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has dosed the first patient in AROAAT2002, an open-label Phase 2 clinical study of ARO-AAT, the company's second generation investigational...

ARWR : 56.42 (-1.21%)
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment with the Company, on December 6, 2019, the Compensation Committee of the Board of Directors...

ARWR : 56.42 (-1.21%)
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-HSD for Treatment of Alcohol and Nonalcohol Related Liver Disease

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has filed an application for approval to begin a Phase 1 clinical trial of ARO-HSD, the company's investigational RNA interference...

ARWR : 56.42 (-1.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ARWR with:

Business Summary

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes....

See More

Key Turning Points

2nd Resistance Point 58.32
1st Resistance Point 57.37
Last Price 56.42
1st Support Level 55.79
2nd Support Level 55.16

See More

52-Week High 73.72
Last Price 56.42
Fibonacci 61.8% 50.34
Fibonacci 50% 43.12
Fibonacci 38.2% 35.89
52-Week Low 12.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar